Tang J, Liu J, Zhou Z, Cui X, Tu H, Jia J
Int J Oral Sci. 2025; 17(1):8.
PMID: 39890798
PMC: 11785813.
DOI: 10.1038/s41368-024-00344-6.
Fu L, Chen H, Huang W, Guo Y, Liu L, Fu Q
Ther Adv Psychopharmacol. 2024; 14:20451253241304219.
PMID: 39650249
PMC: 11624541.
DOI: 10.1177/20451253241304219.
Mohandoss A, Ameen S, Thavarajah R
Indian J Psychol Med. 2024; :02537176241262737.
PMID: 39564322
PMC: 11572559.
DOI: 10.1177/02537176241262737.
Manghani P, Prasad N, Khatri N, Paulino-Ramirez R, Gokhale S, Islam K
Open Forum Infect Dis. 2024; 11(11):ofae577.
PMID: 39507883
PMC: 11540138.
DOI: 10.1093/ofid/ofae577.
Hung C, Ko Y, Chen P, Chung C
Int J Mol Sci. 2024; 25(17).
PMID: 39273170
PMC: 11394840.
DOI: 10.3390/ijms25179221.
Development and validation of betel-year: a clinical tool for quantifying exposure to betel quid chewing, utilizing nuclear morphometric analysis and validated by cytomorphological analysis.
Rajakumar H, Sathyabal V, Jabarulla K, Balamurugesan P
BMC Cancer. 2024; 24(1):930.
PMID: 39090612
PMC: 11293172.
DOI: 10.1186/s12885-024-12685-w.
Maternal betel quid use during pregnancy and child growth: a cohort study from rural Bangladesh.
Islam M, Aktar S, Pervin J, Rahman S, Rahman M, Rahman A
Glob Health Action. 2024; 17(1):2375829.
PMID: 38979658
PMC: 11234907.
DOI: 10.1080/16549716.2024.2375829.
The association between betel quid use and oral potentially malignant and malignant disorders in Southeast Asian and Pacific regions: a systematic review and meta-analysis with GRADE evidence profile.
Jasim A, Li X, Octavia A, Gunardi I, Crocombe L, Sari E
Front Oral Health. 2024; 5:1397179.
PMID: 38846318
PMC: 11153687.
DOI: 10.3389/froh.2024.1397179.
Prevalence, Habit Pattern, and Awareness on Harmful Effects of Tobacco/Areca Nut Use among Patients Visiting a Tertiary Care Center in Sri Lanka.
Subasinghe S, Hettiarachchi P, Jayasinghe R
South Asian J Cancer. 2024; 13(1):4-9.
PMID: 38721098
PMC: 11076066.
DOI: 10.1055/s-0043-1761442.
Comparative Analysis of Tissue Copper Levels in Oral Submucous Fibrosis (OSMF) Patients.
Srivastava R, Singh D, Thomas P, Raza H, Sangamesh N, Bagde H
J Pharm Bioallied Sci. 2024; 16(Suppl 1):S629-S631.
PMID: 38595535
PMC: 11001069.
DOI: 10.4103/jpbs.jpbs_904_23.
What Motivates Betel Quid Chewers to Quit? An Analysis of Several Cessation-Relevant Variables.
Aweau K, Erari S, Im S, Murphy K, Pokhrel P, Herzog T
Subst Use Misuse. 2024; 59(7):1095-1101.
PMID: 38403997
PMC: 11014757.
DOI: 10.1080/10826084.2024.2320388.
Association between Single Nucleotide Polymorphisms in Monoamine Oxidase and the Severity of Addiction to Betel Quid.
Hung C, Ko Y, Chung C
Curr Issues Mol Biol. 2024; 46(2):1010-1019.
PMID: 38392182
PMC: 10887354.
DOI: 10.3390/cimb46020064.
Anti-Neuroinflammatory Effects of on LPS-Stimulated BV2 Cells.
Cho H, Kim D, Oh J, Park S, Kweon B, Bae G
Curr Issues Mol Biol. 2024; 46(1):884-895.
PMID: 38275670
PMC: 10814974.
DOI: 10.3390/cimb46010056.
Facilitator experiences and lessons learned from the Betel nut intervention trial (BENIT).
Rojas G, Erari S, Paulino Y, Herzog T
BMC Public Health. 2024; 24(1):288.
PMID: 38267890
PMC: 10809568.
DOI: 10.1186/s12889-024-17788-4.
Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment.
Zhi Y, Wang Q, Zi M, Zhang S, Ge J, Liu K
Adv Sci (Weinh). 2024; 11(12):e2306515.
PMID: 38229179
PMC: 10966560.
DOI: 10.1002/advs.202306515.
Prevalence of tobacco and areca-nut use among patients attending dental teaching hospital in the central province of Sri Lanka and its association with oral mucosal lesions; a cross sectional study.
Sumithrarachchi S, Athukorala I, Rumy F, Jayasinghe R
J Oral Biol Craniofac Res. 2024; 14(1):39-43.
PMID: 38179108
PMC: 10764264.
DOI: 10.1016/j.jobcr.2023.11.006.
Chemical Composition of Areca Nut and Its Adverse Effects on Human Health.
Dangore-Khasbage S, Bhowate R, Khubchandani M
Cureus. 2023; 15(8):e43739.
PMID: 37731445
PMC: 10507371.
DOI: 10.7759/cureus.43739.
The Betel Nut Intervention Trial (BENIT)-A Randomized Clinical Trial for Areca Nut and Betel Quid Cessation: Primary Outcomes.
Herzog T, Wilkens L, Badowski G, Mendez A, Franke A, Pokhrel P
Int J Environ Res Public Health. 2023; 20(16).
PMID: 37623205
PMC: 10454381.
DOI: 10.3390/ijerph20166622.
Interleukin-13 contributes to the occurrence of oral submucosal fibrosis.
Wang L, Tang Z, Huang J
J Cell Mol Med. 2023; 27(13):1797-1805.
PMID: 37337411
PMC: 10315707.
DOI: 10.1111/jcmm.17761.
Bacteria in the oral cavity of individuals consuming intoxicating substances.
Khan R, Devi K, Barman M, Bhagawati M, Sarmah R
PLoS One. 2023; 18(5):e0285753.
PMID: 37235563
PMC: 10218728.
DOI: 10.1371/journal.pone.0285753.